GALDY (Galderma Group AG) ROCE %: 8.28% (As of Dec. 2025)


GALDY Galderma Group AG GALDY
21 GF Score
Price $44.05
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG ROCE %?

Galderma Group AG GALDY -0.40% 21 ROCE % is 8.28% as of Dec. 2025. GuruFocus rates GALDY with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Galderma Group AG's annualized ROCE % for the quarter that ended in Dec. 2025 was 8.28%.

Galderma Group AG  (OTCPK:GALDY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Galderma Group AG ROCE % Related Terms

Galderma Group AG ROCE % Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG ROCE % Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
0.00 0.00 5.28 6.06 7.25

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial 5.39 5.70 6.37 6.27 8.28
GALDY
21GF Score
Galderma Group AG GALDY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG ROCE % Calculation

Galderma Group AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=813/( ( (12617 - 1528) + (13393 - 2055) )/ 2 )
=813/( (11089+11338)/ 2 )
=813/11213.5
=7.25 %

Galderma Group AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=930/( ( (12877 - 1750) + (13393 - 2055) )/ 2 )
=930/( ( 11127 + 11338 )/ 2 )
=930/11232.5
=8.28 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.28% mean?
Galderma Group AG (GALDY) has a ROCE % of 8.28% as of Dec. 2025.
Is Galderma Group AG's ROCE % too high?
Galderma Group AG's current ROCE % is 8.28%. The Drug Manufacturers industry median ROCE % is 7.00. Galderma Group AG's value of 8.28% is 18.4% above this industry median. Overall, Galderma Group AG has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's ROCE % compare to ZTS and UTHR?
Galderma Group AG's ROCE % of 8.28% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Galderma Group AG's value of 8.28% is 18.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galderma Group AG's current ROCE % of 8.28% is 18.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galderma Group AG's current ROCE % is 8.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (GALDY) has a current ROCE % of 8.28%. The current ROCE % is 8.28% and 18.4% above the Drug Manufacturers industry median of 7.00. Galderma Group AG's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Galderma Group AG (GALDY), the current ROCE % is 8.28% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
21GF Score

Get the complete analysis for GALDY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$44.05
Price